SIREN : 814359709
MEDISYNAPS is a French company founded 10 years ago, specialized in the sector Activités spécialisées, scientifiques et techniques diverses. Based in VINCENNES (94300), this company of category PME shows in 2019 a revenue of 525€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|
| Revenue | 525 € | 1 050 € | 6 600 € | N/C |
| Net income | -2 366 € | -3 692 € | 4 403 € | -2 010 € |
| EBITDA | -429 € | -1 920 € | 4 818 € | -2 010 € |
| Net margin | -450.7% | -351.6% | 66.7% | N/C |
In 2019, MEDISYNAPS achieves revenue of 525 €. Revenue is declining over the period 2017-2019 (CAGR: -71.8%). Significant drop of -50% vs 2018. After deducting consumption (0 €), gross margin stands at 525 €, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -429 €, representing -81.7% of revenue. Positive scissor effect: EBITDA margin improves by +101.1 pts, sign of improved operational efficiency. Negative EBITDA means operations do not cover current expenses: concerning situation. Net income is negative at -2 k€ (-450.7% of revenue), which will impact equity.
525 €
525 €
-429 €
-1 532 €
-2 366 €
-81.7%
The debt ratio (= Financial debt / Equity x 100) stands at 51%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 11%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
51.014%
10.634%
-256.0%
0.0
In 2019, the debt ratio of MEDISYNAPS (51.01) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2019, the financial autonomy of MEDISYNAPS (10.6%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2019, the repayment capacity of MEDISYNAPS (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
The liquidity ratio (= Current assets / Current liabilities) stands at 126.33. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
126.335
-194.406
In 2019, the liquidity ratio of MEDISYNAPS (126.33) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
In 2019, the interest coverage of MEDISYNAPS (-194.4x) ranks in the bottom 25% of the sector. This ratio indicates how many times operating income covers interest expenses. Low coverage may indicate fragility to rate or income variations.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 306 days. Excellent situation: suppliers finance 306 days of the operating cycle (retail model). WCR is negative (-771 days): operations structurally generate cash.
-1 124 €
0 j
306 j
0 j
-771 j
Based on 98 transactions of similar company sales
(all years),
the value of MEDISYNAPS is estimated at
190 €
(range 62€ - 322€).
The price/revenue ratio is 0.36x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 98 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare MEDISYNAPS with other companies in the same sector:
Voir toutes les statistiques du secteur Activités spécialisées, scientifiques et techniques diverses
The revenue of MEDISYNAPS in 2019 is 525€.
MEDISYNAPS recorded a net loss in 2019.
The headquarters of MEDISYNAPS is located in VINCENNES (94300), in the department Val-de-Marne.
The tax return of MEDISYNAPS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
MEDISYNAPS operates in the sector Activités spécialisées, scientifiques et techniques diverses (NAF code 74.90B). See the 'Sector positioning' section above to compare the company with its competitors.